National platform for studying inflammatory heart disease
Official title: Creation of a National Multicenter Platform for the Study of Inflammatory Myocardial Disease: Pre-MYO Cohort
Run by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · NCT06898762 · Data updated 2026-11-12
This study is trying to gather information from patients with suspected heart inflammation to better understand their symptoms, treatment, and the factors that affect their condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia Academic / other |
| Locations | 1 site (Murcia, Murcia) |
| Status | Recruiting |
| Started | April 9, 2023 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | March 27, 2025 |
| Trial ID | NCT06898762 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals presenting symptoms compatible with myocarditis, such as acute chest pain, dyspnea, or unexplained arrhythmias, along with objective findings from diagnostic tests.
✕Probably not a fit
Patients without symptoms or objective findings indicative of myocarditis or inflammatory cardiomyopathy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to create a comprehensive national cohort of patients with suspected myocarditis and inflammatory cardiomyopathy. It will characterize their clinical features, management, and biomarkers, while also validating a new diagnostic biomarker against conventional methods. The study will explore genetic mutations and environmental factors that may influence the severity and treatment response of myocarditis, as well as the observed differences in incidence between genders and across age groups.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and personalized treatment strategies for patients with myocarditis.
How similar studies have gone: While there have been studies on myocarditis, this approach of creating a national multicenter platform for comprehensive characterization is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: • Presence of at least one compatible symptom and at least one objective finding in diagnostic tests (Figure 2), according to the consensus document of the European Society of Cardiology (1): A. Clinical presentation: * Acute chest pain: pericardial or pseudo-ischemic. * Dyspnea on exertion or at rest for up to 3 months. * Dyspnea on exertion or at rest for 3 months - 1 year. * Unexplained palpitations / arrhythmias, sudden death recovered. * Unexplained cardiogenic shock. B. Findings in complementary tests: * ECG: new onset AV block, new onset bundle branch block, ST segment elevation/depression, T wave inversion * Elevation of TnI/TnT * Segmental or global contractility alterations not explained by other causes * Positive Lake Louise criteria in cardiac MRI (13) (Annex III Figure S1) • Patients who have given their informed consent.
Where it's running
-
Hcuva
Murcia, Murcia, Spain Recruiting
Study contacts
- Principal investigator: Domingo Pascual Figal, MD — Hcuva
- Study coordinator: Domingo Pascual Figal, MD
- Email: coordinacion@premyo.org
- Phone: 868885273
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care
This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.
-
Using Spectral CT to Diagnose Myocarditis in Patients with Chest Pain
This study is testing if a new type of CT scan can help doctors better diagnose myocarditis and other causes of chest pain in patients who might not have heart disease.
-
Ibuprofen versus acetaminophen for uncomplicated acute myocarditis
This trial will test whether a 3-week ibuprofen taper compared with acetaminophen helps adults hospitalized with uncomplicated acute myocarditis (LVEF ≥50%) reduce heart scarring seen on cardiac MRI at 6 months.
-
Evaluating endomyocardial biopsy and tailored treatments for pediatric inflammatory heart disease
This study is testing how a heart tissue sample and personalized treatments can help kids with inflammatory heart disease, especially those with myocarditis and heart rhythm issues.
-
Colchicine treatment for chronic inflammatory cardiomyopathy
This study tests if colchicine can help people with chronic inflammatory cardiomyopathy who have heart issues feel better by reducing inflammation in their hearts.
-
National surveillance of myocarditis and pericarditis after mRNA COVID-19 vaccination
This study is trying to see how mRNA COVID-19 vaccines might affect heart health by following patients who develop heart inflammation after getting vaccinated.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.